Director, Quantitative Systems Pharmacology, Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis
Bristol Myers Squibb
Alexander Ratushny, Ph.D., is a Director of Quantitative Systems Pharmacology, Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis at Bristol Myers Squibb. In his current position, Alexander leads multiple initiatives and collaborations that focus on bringing systems approaches to clinical research programs. His team develops computational approaches and mathematical models to inform and impact programs at different stages of development, ranging from early discovery and preclinical projects to late translational and clinical programs.
Prior to joining Bristol Myers Squibb, Alexander was a Group Leader in Informatics and Predictive Sciences at Celgene. Alexander is an accomplished scientist with over 20 years of experience in the field of systems biology and biomedical research. He received his Ph.D. in 2006 from the Institute of Cytology and Genetics in Novosibirsk, Russia, and performed his postdoctoral studies at the Institute for Systems Biology, Seattle BioMed, and Center for Infectious Disease Research in Seattle, WA.
Throughout his career, Alexander has co-authored over 50 peer-reviewed scientific publications and book chapters, demonstrating his expertise and significant contributions to the field.
Monday, September 11, 2023
1:30 PM - 5:00 PM PT
Disclosure(s): Bristol Myers Squibb: Employment (), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) ()
Monday, September 11, 2023
1:30 PM - 5:00 PM PT
Disclosure(s): Bristol Myers Squibb: Employment (), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) ()